{"id":3983,"date":"2020-09-15T13:52:33","date_gmt":"2020-09-15T11:52:33","guid":{"rendered":"https:\/\/www.ab-science.com\/accueil\/"},"modified":"2026-08-05T21:12:50","modified_gmt":"2026-08-05T19:12:50","slug":"accueil","status":"publish","type":"page","link":"https:\/\/ab-science.excalibra.com\/fr\/","title":{"rendered":"Accueil"},"content":{"rendered":"<div class=\"wpb-content-wrapper\" id=\"wpb-content-root\"><p>[vc_row gap=\u00a0\u00bb0px\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/2&Prime;]<div id=\"ultimate-heading-76036a749277a0a49\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-76036a749277a0a49 uvc-542 headingab uvc-heading-default-font-sizes\" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-76036a749277a0a49 h2'  data-responsive-json-new='{\"font-size\":\"\",\"line-height\":\"\"}' ><h2 style=\"--font-weight:theme;margin-bottom:20px;\">INNOVATION TH\u00c9RAPEUTIQUE CIBL\u00c9E<\/h2><\/div><\/div>[vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<\/p>\n<h2 style=\"font-size: 60px; line-height: 1em; font-weight: 500;\">La discipline scientifique<br \/>\n<span style=\"color: #5e87c5; font-style: italic;\">au service des patients.<\/span><\/h2>\n<p>[\/vc_column_text][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]AB Science con\u00e7oit des traitements innovants pour les maladies \u00e0 fort besoin m\u00e9dical non satisfait, avec une priorit\u00e9 : transformer la recherche de pr\u00e9cision en b\u00e9n\u00e9fice clinique.[\/vc_column_text]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-2c7b9910312c8e3f88e42dae2db35a6d.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-2c7b9910312c8e3f88e42dae2db35a6d > i {\n  margin-right: 8px;\n}<\/style><a href=\"#\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off ico-right-side btn-inline-left \" id=\"default-btn-2c7b9910312c8e3f88e42dae2db35a6d\"><span>D\u00e9couvrir notre science<\/span><i class=\"icomoon-the7-font-the7-link-03\"><\/i><\/a><style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-47a3018bca68bf4ffd8486ec85d92265.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-47a3018bca68bf4ffd8486ec85d92265 > i {\n  margin-right: 8px;\n}<\/style><a href=\"https:\/\/ab-science.excalibra.com\/fr\/pipeline\/\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off revert decalage-gauche btn-inline-left \" id=\"default-btn-47a3018bca68bf4ffd8486ec85d92265\"><span>Explorer le pipeline<\/span><\/a>[\/vc_column][vc_column css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/2&Prime; offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-6 vc_col-sm-inherit\u00a0\u00bb][vc_single_image image=\u00a0\u00bb11156&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785945735293{background-color: #EAF1FA !important;}\u00a0\u00bb][vc_row_inner gap=\u00a0\u00bb0px\u00a0\u00bb content_placement=\u00a0\u00bbtop\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785957111741{border-top-width: 1px !important;border-top-style: solid !important;border-color: #DCE5EF !important;}\u00a0\u00bb el_class=\u00a0\u00bbchiffres-cles\u00a0\u00bb][vc_column_inner css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/4&Prime; css=\u00a0\u00bb.vc_custom_1785956971384{margin-top: 0px !important;padding-top: 15px !important;border-color: #DCE5EF !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-3 vc_col-sm-inherit\u00a0\u00bb][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785957133022{margin-top: 0px !important;margin-bottom: 15px !important;}\u00a0\u00bb]<\/p>\n<h2 style=\"margin-bottom: 0px; text-align: center;\">2001<\/h2>\n<p style=\"font-size: 80%; text-align: center;\">Cr\u00e9ation \u00e0 Paris<\/p>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/2&Prime; css=\u00a0\u00bb.vc_custom_1785956993037{margin-top: 0px !important;padding-top: 15px !important;border-color: #DCE5EF !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-6 vc_col-sm-inherit\u00a0\u00bb][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785957165973{margin-top: 0px !important;margin-bottom: 15px !important;}\u00a0\u00bb]<\/p>\n<h2 style=\"margin-bottom: 0px; text-align: center;\">2<\/h2>\n<p style=\"font-size: 80%; text-align: center;\">Programmes prioritaires<\/p>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/4&Prime; css=\u00a0\u00bb.vc_custom_1785957004158{margin-top: 0px !important;padding-top: 15px !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-3 vc_col-sm-inherit\u00a0\u00bb][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785957145072{margin-top: 0px !important;margin-bottom: 15px !important;}\u00a0\u00bb]<\/p>\n<h2 style=\"margin-bottom: 0px; text-align: center;\">AB<\/h2>\n<p style=\"font-size: 80%; text-align: center;\">Euronext Paris<\/p>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a749277a0e09\" data-id=\"6a749277a0e09\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb gap=\u00a0\u00bb0px\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785955349719{background-color: #1D293D !important;}\u00a0\u00bb][vc_column][vc_row_inner gap=\u00a0\u00bb0px\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785955401892{border-color: #EB5B25 !important;}\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<span style=\"color: #eb5b25;\"><strong>01<\/strong><\/span><\/p>\n<h2><span style=\"color: #dce5ef; font-size: 12px; letter-spacing: 1.5px;\">NOTRE ENGAGEMENT<\/span><\/h2>\n<h3><span style=\"color: #ffffff; font-size: 48px; line-height: 54px; font-weight: 500;\">Se concentrer l\u00e0 o\u00f9 les options th\u00e9rapeutiques sont limit\u00e9es.<\/span><\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/2&Prime; css=\u00a0\u00bb.vc_custom_1785955642158{border-left-width: 4px !important;padding-left: 30px !important;border-left-style: solid !important;border-color: #EB5B25 !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-6 vc_col-sm-inherit\u00a0\u00bb]<div id=\"ultimate-heading-60756a749277a0e6f\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-60756a749277a0e6f uvc-4791 \" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-60756a749277a0e6f h2'  data-responsive-json-new='{\"font-size\":\"desktop:60px;\",\"line-height\":\"\"}' ><h2 style=\"--font-weight:theme;color:#EB5B25;margin-bottom:0px;\">\u201c<\/h2><\/div><\/div><div id=\"ultimate-heading-37396a749277a0efe\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-37396a749277a0efe uvc-874 \" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-37396a749277a0efe h2'  data-responsive-json-new='{\"font-size\":\"desktop:48px;\",\"line-height\":\"\"}' ><h2 style=\"font-style:italic;--font-weight:theme;color:#FFFFFF;margin-top:0px;margin-bottom:20px;\">Discipline serving the patients<\/h2><\/div><\/div>[vc_column_text]Nous poursuivons l\u2019excellence scientifique avec rigueur et d\u00e9termination, exclusivement dans des maladies o\u00f9 les patients disposent de peu ou pas d\u2019alternatives th\u00e9rapeutiques.[\/vc_column_text]<div id=\"ultimate-heading-14436a749277a0f6d\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-14436a749277a0f6d uvc-9550  uvc-heading-default-font-sizes\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><\/div>[\/vc_column_inner][\/vc_row_inner]<div class=\"ult-spacer spacer-6a749277a0fba\" data-id=\"6a749277a0fba\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"40\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a749277a0fed\" data-id=\"6a749277a0fed\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row gap=\u00a0\u00bb0px\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb][vc_column][vc_row_inner gap=\u00a0\u00bb0px\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<span style=\"color: #eb5b25;\"><strong>02<\/strong><\/span><\/p>\n<h2><span style=\"color: #5e87c5; font-size: 12px; letter-spacing: 1.5px;\">SCIENCE DE PR\u00c9CISION<\/span><\/h2>\n<h3><span style=\"color: #1d293d; font-size: 48px; line-height: 54px; font-weight: 500;\">Cibler les m\u00e9canismes qui font progresser la maladie.<\/span><\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/2&Prime;][vc_column_text]Notre approche associe inhibition s\u00e9lective des prot\u00e9ines kinases et agents cibl\u00e9s de nouvelle g\u00e9n\u00e9ration, afin d\u2019agir sur la biologie de la maladie tout en limitant les effets hors cible[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a749277a101c\" data-id=\"6a749277a101c\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row gap=\u00a0\u00bb30px\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb css_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/2&Prime; css=\u00a0\u00bb.vc_custom_1785949033276{border-top-width: 10px !important;padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;background-color: #EAF1FA !important;border-top-style: solid !important;border-color: #EB5B25 !important;border-radius: 25px !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-6 vc_col-sm-inherit\u00a0\u00bb][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<span style=\"color: #eb5b25;\"><strong>01<\/strong><\/span><\/p>\n<h2><span style=\"color: #5e87c5; font-size: 12px; text-transform: uppercase; letter-spacing: 1.5px;\">Inhibiteur s\u00e9lectif de prot\u00e9ines kinases<\/span><\/h2>\n<h3><span style=\"color: #1d293d; font-size: 48px; line-height: 54px; font-weight: 500;\">Mastinib<\/span><\/h3>\n<p>Cible les mastocytes et les cellules gliales via des kinases cl\u00e9s impliqu\u00e9es dans la neuro-inflammation et la progression de pathologies s\u00e9v\u00e8res.[\/vc_column_text]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83 > i {\n  margin-right: 8px;\n}<\/style><a href=\"#\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off revert btn-inline-left \" id=\"default-btn-4f33db27f2cbdb735ce1c11ded5b0d83\"><span>Comprendre le m\u00e9canisme<\/span><\/a>[\/vc_column][vc_column css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/2&Prime; css=\u00a0\u00bb.vc_custom_1785949045882{border-top-width: 10px !important;padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;background-color: #EAF1FA !important;border-top-style: solid !important;border-color: #5E87C5 !important;border-radius: 25px !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-6 vc_col-sm-inherit\u00a0\u00bb][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<span style=\"color: #eb5b25;\"><strong>02<\/strong><\/span><\/p>\n<h2><span style=\"color: #5e87c5; font-size: 12px; text-transform: uppercase; letter-spacing: 1.5px;\">Agent d\u00e9stabilisateur de microtubules<\/span><\/h2>\n<h3><span style=\"color: #1d293d; font-size: 48px; line-height: 54px; font-weight: 500;\">AB8939<\/span><\/h3>\n<p>Con\u00e7u pour conserver son activit\u00e9 dans les tumeurs r\u00e9sistantes et ouvrir de nouvelles options dans les cancers h\u00e9matologiques difficiles \u00e0 traiter.[\/vc_column_text]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83 > i {\n  margin-right: 8px;\n}<\/style><a href=\"#\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off revert btn-inline-left \" id=\"default-btn-4f33db27f2cbdb735ce1c11ded5b0d83\"><span>D\u00e9couvrir AB8939<\/span><\/a>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a749277a1207\" data-id=\"6a749277a1207\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb gap=\u00a0\u00bb0px\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785954497528{background-color: #335F9D !important;}\u00a0\u00bb][vc_column][vc_row_inner gap=\u00a0\u00bb0px\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/3&Prime;][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<span style=\"color: #eb5b25;\"><strong>03<\/strong><\/span><\/p>\n<h2><span style=\"color: #dce5ef; font-size: 12px; letter-spacing: 1.5px;\">PIPELINE CLINIQUE<\/span><\/h2>\n<h3><span style=\"color: #fff; font-size: 48px; line-height: 54px; font-weight: 500;\">Des priorit\u00e9s claires, orient\u00e9es vers l\u2019impact..<\/span><\/h3>\n<p>[\/vc_column_text][vc_column_text]<\/p>\n<p style=\"color: #dce5ef;\">Les ressources cliniques se concentrent sur les indications au besoin m\u00e9dical le plus fort et au parcours r\u00e9glementaire le plus lisible.<\/p>\n<p>[\/vc_column_text]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83 > i {\n  margin-right: 8px;\n}<\/style><a href=\"#\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off revert btn-inline-left \" id=\"default-btn-4f33db27f2cbdb735ce1c11ded5b0d83\"><span>Voir le pipeline complet<\/span><\/a>[\/vc_column_inner][vc_column_inner width=\u00a0\u00bb2\/3&Prime;][vc_column_text]<\/p>\n<div class=\"pipeline-table-wrapper\">\n<table class=\"pipeline-table\">\n<thead>\n<tr>\n<th scope=\"col\">Programme<\/th>\n<th scope=\"col\">Indication<\/th>\n<th scope=\"col\">Phase<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"programme programme-prioritaire\"><br \/>\nMasitinib<br \/>\n<\/span><\/td>\n<td><strong class=\"indication-code\">SLA<\/strong><br \/>\n<span class=\"indication-name\"><br \/>\nScl\u00e9rose lat\u00e9rale amyotrophique<br \/>\n<\/span><\/td>\n<td>\n<div class=\"phase-information\"><span class=\"phase-badge\">Phase 3<\/span><br \/>\n<strong class=\"priority-label\">Prioritaire<\/strong><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td><span class=\"programme programme-prioritaire\"><br \/>\nAB8939<br \/>\n<\/span><\/td>\n<td><strong class=\"indication-code\">LMA<\/strong><br \/>\n<span class=\"indication-name\"><br \/>\nLeuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb<br \/>\n<\/span><\/td>\n<td>\n<div class=\"phase-information\"><span class=\"phase-badge\">Phase 1<\/span><br \/>\n<strong class=\"priority-label\">Prioritaire<\/strong><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td><span class=\"programme\">Masitinib<\/span><\/td>\n<td><strong class=\"indication-code\">MSI<\/strong><br \/>\n<span class=\"indication-name\"><br \/>\nMastocytose syst\u00e9mique indolente<br \/>\n<\/span><\/td>\n<td>\n<div class=\"phase-information\"><span class=\"phase-badge\">Phase 3<\/span><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td><span class=\"programme\">Masitinib<\/span><\/td>\n<td><strong class=\"indication-code\">SEP<\/strong><br \/>\n<span class=\"indication-name\"><br \/>\nScl\u00e9rose en plaques progressive<br \/>\n<\/span><\/td>\n<td>\n<div class=\"phase-information\"><span class=\"phase-badge\">Phase 3<\/span><\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner]<div class=\"ult-spacer spacer-6a749277a1300\" data-id=\"6a749277a1300\" data-height=\"20\" data-height-mobile=\"10\" data-height-tab=\"20\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"10\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a749277a132f\" data-id=\"6a749277a132f\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<span style=\"color: #eb5b25;\"><strong>04<\/strong><\/span><\/p>\n<h2><span style=\"color: #5e87c5; font-size: 12px; letter-spacing: 1.5px;\">ACTUALIT\u00c9S<\/span><\/h2>\n<p>[\/vc_column_text][vc_row_inner][vc_column_inner width=\u00a0\u00bb5\/6&Prime;][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<\/p>\n<h3><span style=\"color: #1d293d; font-size: 48px; line-height: 54px; font-weight: 500;\">Les derni\u00e8res avanc\u00e9es d&rsquo;AB SCIENCE.<\/span><\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6&Prime;]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-4f33db27f2cbdb735ce1c11ded5b0d83 > i {\n  margin-right: 8px;\n}<\/style><a href=\"#\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off revert btn-inline-left \" id=\"default-btn-4f33db27f2cbdb735ce1c11ded5b0d83\"><span>Tous les communiqu\u00e9s<\/span><\/a>[\/vc_column_inner][\/vc_row_inner]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on.classic-layout-list article {\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on.classic-layout-list article:first-of-type {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.classic-layout-list.mode-list .post-entry-content {\n  width: calc(100% - );\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.classic-layout-list.mode-list .no-img .post-entry-content {\n  width: 100%;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .filter-bg-decoration .filter-categories a.act {\n  color: #fff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on:not(.mode-masonry) article {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-thumbnail-wrap {\n  padding: 0px 0px 0px 0px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.enable-bg-rollover .post-thumbnail-rollover:after {\n  background: -webkit-linear-gradient();\n  background: linear-gradient();\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico {\n  width: 44px;\n  height: 44px;\n  line-height: 44px;\n  border-radius: 100px;\n  margin: -22px 0 0 -22px;\n  border-width: 0px;\n  color: #ffffff;\n}\n.bottom-overlap-layout-list.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico {\n  margin-top: -72px;\n}\n.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico,\n.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico {\n  margin: 0 0 10px;\n}\n.content-align-center.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico,\n.content-align-center.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico {\n  margin: 0 auto 10px;\n}\n.dt-icon-bg-on.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico {\n  background: rgba(255,255,255,0.3);\n  box-shadow: none;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico:before {\n  font-size: 32px;\n  line-height: 44px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .gallery-zoom-ico:before {\n  color: #ffffff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .entry-title,\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.owl-carousel .entry-title {\n  margin-bottom: 5px;\n  font-weight: bold;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .entry-meta {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .portfolio-categories {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .entry-excerpt {\n  margin-bottom: 5px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.centered-layout-list) .post-entry-content {\n  padding: 25px 0px 30px 0px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.centered-layout-list):not(.content-bg-on):not(.mode-list) .no-img .post-entry-content {\n  padding: 0;\n}\n@media screen and (max-width: ) {\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 article {\n    -ms-flex-flow: column nowrap;\n    flex-flow: column nowrap;\n    margin-top: 20px;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on article {\n    border: none;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.content-bg-on.centered-layout-list article {\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.blog-shortcode.dividers-on article,\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on.classic-layout-list article {\n    margin-top: 20px;\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.blog-shortcode.dividers-on article:first-of-type,\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.dividers-on.classic-layout-list article:first-of-type {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-entry-content {\n    width: 100%;\n    margin: 0;\n    top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-thumbnail-wrap {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-entry-content:after {\n    display: none;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .project-even .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.centered-layout-list .post-thumbnail-wrap {\n    -ms-flex-order: 0;\n    order: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.centered-layout-list .post-entry-title-content {\n    -ms-flex-order: 1;\n    order: 1;\n    width: 100%;\n    padding: 20px 20px 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.centered-layout-list .post-entry-content {\n    -ms-flex-order: 2;\n    order: 2;\n    padding-top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .fancy-categories {\n    top: 10px;\n    left: 10px;\n    bottom: auto;\n    right: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .fancy-date a {\n    top: 10px;\n    right: 10px;\n    left: auto;\n    bottom: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-entry-content {\n    padding: 20px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .entry-title {\n    margin: 3px 0 5px;\n    font-size: 20px;\n    line-height: 26px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .entry-meta {\n    margin: 5px 0 5px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .entry-excerpt {\n    margin: 15px 0 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-details {\n    margin: 5px 0 10px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 .post-details.details-type-link {\n    margin-bottom: 2px;\n  }\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.resize-by-browser-width) .dt-css-grid {\n  grid-row-gap: 30px;\n  grid-column-gap: 30px;\n  grid-template-columns: repeat(auto-fill,minmax(,1fr));\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.resize-by-browser-width) .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.resize-by-browser-width) .dt-css-grid,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.resize-by-browser-width) .dt-css-grid {\n  display: flex;\n  flex-flow: row wrap;\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.resize-by-browser-width) .dt-css-grid .wf-cell,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143:not(.resize-by-browser-width) .dt-css-grid .wf-cell {\n  flex: 1 0 ;\n  max-width: 100%;\n  padding: 15px;\n  box-sizing: border-box;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid {\n  grid-template-columns: repeat(3,1fr);\n  grid-template-rows: auto;\n  grid-column-gap: 30px;\n  grid-row-gap: 30px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid {\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell {\n  width: 33.333333333333%;\n  padding: 15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n  width: calc(33.333333333333%) * 2;\n}\n.blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width:not(.centered-layout-list):not(.content-bg-on) .dt-css-grid {\n  grid-row-gap: 0px;\n}\n@media screen and (max-width: 1199px) {\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(3,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 33.333333333333%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(33.333333333333%)*2;\n  }\n}\n@media screen and (max-width: 991px) {\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(2,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 50%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(50%)*2;\n  }\n}\n@media screen and (max-width: 767px) {\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(1,1fr);\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .double-width {\n    grid-column: span 1;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 100%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(100%)*2;\n  }\n}<\/style><div class=\"blog-shortcode blog-masonry-shortcode-id-b09a248e0b8524cde2bd630cb30c7143 mode-grid classic-layout-list content-bg-on jquery-filter scale-img dt-css-grid-wrap dt-icon-bg-off resize-by-browser-width loading-effect-move-up description-under-image \" data-padding=\"15px\" data-cur-page=\"1\" data-post-limit=\"-1\" data-pagination-mode=\"none\" data-desktop-columns-num=\"3\" data-v-tablet-columns-num=\"2\" data-h-tablet-columns-num=\"3\" data-phone-columns-num=\"1\" data-width=\"0px\" data-columns=\"0\"><div class=\"dt-css-grid\" ><div class=\"visible wf-cell\" data-post-id=\"10839\" data-date=\"2026-07-10T17:45:02+02:00\" data-name=\"AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\"><article class=\"post project-odd visible no-img post-10839 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\" data-date=\"2026-07-10T17:45:02+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-fait-le-point-sur-son-programme-clinique-avec-larret-de-certaines-etudes-cliniques-non-prioritaires-en-vue-de-se-concentrer-sur-deux-programmes-cliniques\/\" title=\"AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\" rel=\"bookmark\">AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/ab-science.excalibra.com\/fr\/2026\/07\/10\/\" title=\"17h45\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-07-10T17:45:02+02:00\">10 juillet 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 10\/07\/2026 \u2013\u00a0AB Science fait aujourd\u2019hui le point sur son programme de d\u00e9veloppement clinique et annonce l\u2019arr\u00eat de certaines \u00e9tudes clinique non prioritaires, en vue de se concentrer sur deux programmes cliniques, le programme AB8939 dans la LMA et le programme masitinib dans la SLA [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-fait-le-point-sur-son-programme-clinique-avec-larret-de-certaines-etudes-cliniques-non-prioritaires-en-vue-de-se-concentrer-sur-deux-programmes-cliniques\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10832\" data-date=\"2026-07-08T10:43:04+02:00\" data-name=\"Le Conseil d&#039;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&#039;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\"><article class=\"post project-odd visible no-img post-10832 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\" data-date=\"2026-07-08T10:43:04+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/ab-science.excalibra.com\/fr\/le-conseil-dadministration-dab-science-fait-evoluer-la-gouvernance-afin-dengager-une-nouvelle-etape-du-developpement-de-la-societe\/\" title=\"Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\" rel=\"bookmark\">Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/ab-science.excalibra.com\/fr\/2026\/07\/08\/\" title=\"10h43\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-07-08T10:43:04+02:00\">8 juillet 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 08\/07\/2026 \u2013\u00a0Nomination de St\u00e9phane LEDERMANN en qualit\u00e9 de Pr\u00e9sident Directeur G\u00e9n\u00e9ral [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/ab-science.excalibra.com\/fr\/le-conseil-dadministration-dab-science-fait-evoluer-la-gouvernance-afin-dengager-une-nouvelle-etape-du-developpement-de-la-societe\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10815\" data-date=\"2026-07-01T07:55:58+02:00\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\"><article class=\"post project-odd visible no-img post-10815 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\" data-date=\"2026-07-01T07:55:58+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-23-millions-deuros\/\" title=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\" rel=\"bookmark\">AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/ab-science.excalibra.com\/fr\/2026\/07\/01\/\" title=\"7h55\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-07-01T07:55:58+02:00\">1 juillet 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 01\/07\/2026 \u2013 AB Science annonce aujourd&rsquo;hui le succ\u00e8s d&rsquo;une augmentation de capital d&rsquo;un montant brut total de 2,3 millions d\u2019euros souscrite par un nombre limit\u00e9 d&rsquo;investisseurs [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-23-millions-deuros\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10790\" data-date=\"2026-06-29T07:27:17+02:00\" data-name=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\"><article class=\"post project-odd visible no-img post-10790 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\" data-date=\"2026-06-29T07:27:17+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-annonce-lachevement-de-letape-3-de-la-phase-1-evaluant-la-combinaison-dab8939-et-du-venetoclax-dans-le-traitement-de-la-lma-refractaire-ou-en-rechute\/\" title=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\" rel=\"bookmark\">AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/ab-science.excalibra.com\/fr\/2026\/06\/29\/\" title=\"7h27\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-29T07:27:17+02:00\">29 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 29\/06\/2026 \u2013\u00a0AB Science fait aujourd\u2019hui le point sur l\u2019\u00e9tude de phase 1 de la mol\u00e9cule AB8939 et l\u2019ach\u00e8vement de l\u2019\u00e9tape 3, \u00e9valuant la combinaison d\u2019AB8939 + v\u00e9n\u00e9toclax chez des patients atteints de leuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-annonce-lachevement-de-letape-3-de-la-phase-1-evaluant-la-combinaison-dab8939-et-du-venetoclax-dans-le-traitement-de-la-lma-refractaire-ou-en-rechute\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10773\" data-date=\"2026-06-17T17:47:20+02:00\" data-name=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\"><article class=\"post project-odd visible no-img post-10773 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\" data-date=\"2026-06-17T17:47:20+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/ab-science.excalibra.com\/fr\/le-brevet-dab-science-concernant-le-masitinib-dans-le-traitement-du-cancer-de-la-prostate-metastatique-hormono-resistant-a-ete-officiellement-delivre-aux-etats-unis-avec-une-duree-de-protecti\/\" title=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\" rel=\"bookmark\">Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/ab-science.excalibra.com\/fr\/2026\/06\/17\/\" title=\"17h47\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-17T17:47:20+02:00\">17 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 17\/06\/2026 \u2013\u00a0AB Science annonce aujourd\u2019hui que l\u2019Office am\u00e9ricain des brevets a officiellement d\u00e9livr\u00e9 un brevet relatif aux m\u00e9thodes de traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant (mCRPC) avec sa mol\u00e9cule phare, le masitinib [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/ab-science.excalibra.com\/fr\/le-brevet-dab-science-concernant-le-masitinib-dans-le-traitement-du-cancer-de-la-prostate-metastatique-hormono-resistant-a-ete-officiellement-delivre-aux-etats-unis-avec-une-duree-de-protecti\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10746\" data-date=\"2026-06-09T18:33:53+02:00\" data-name=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&#039;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\"><article class=\"post project-odd visible no-img post-10746 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\" data-date=\"2026-06-09T18:33:53+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-presentera-lors-du-congres-annuel-2026-de-lencals-les-donnees-de-survie-issues-du-programme-clinique-du-masitinib-dans-la-sla\/\" title=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\" rel=\"bookmark\">AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/ab-science.excalibra.com\/fr\/2026\/06\/09\/\" title=\"18h33\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-09T18:33:53+02:00\">9 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 09\/06\/2026 \u2013\u00a0AB Science a annonc\u00e9 aujourd&rsquo;hui que de nouvelles analyses issues de son essai de phase 3 dans la scl\u00e9rose lat\u00e9rale amyotrophique (AB10015) ont \u00e9t\u00e9 accept\u00e9es pour une pr\u00e9sentation lors de la r\u00e9union annuelle de l&rsquo;ENCALS (24-26 juin 2026, Madrid, Espagne) [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/ab-science.excalibra.com\/fr\/ab-science-presentera-lors-du-congres-annuel-2026-de-lencals-les-donnees-de-survie-issues-du-programme-clinique-du-masitinib-dans-la-sla\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><\/div><!-- iso-container|iso-grid --><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a749277b608c\" data-id=\"6a749277b608c\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row gap=\u00a0\u00bb0px\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785951067978{border-left-width: 10px !important;background-color: #EAF1FA !important;border-left-style: solid !important;border-color: #EB5B25 !important;border-top-left-radius: 25px !important;border-bottom-left-radius: 25px !important;}\u00a0\u00bb][vc_column][vc_row_inner gap=\u00a0\u00bb0px\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785951794861{border-color: #5E87C5 !important;}\u00a0\u00bb][vc_column_inner css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb2\/3&Prime; css=\u00a0\u00bb.vc_custom_1785954259355{margin-left: 30px !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-8 vc_col-sm-inherit\u00a0\u00bb][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]<span style=\"color: #eb5b25;\"><strong>05<\/strong><\/span><\/p>\n<h2><span style=\"color: #5e87c5; font-size: 12px; letter-spacing: 1.5px;\">INVESTISSEURS<\/span><\/h2>\n<h3><span style=\"color: #1d293d; font-size: 48px; line-height: 54px; font-weight: 500;\">Une information financi\u00e8re claire et accessible.<\/span><\/h3>\n<p>[\/vc_column_text][vc_column_text]R\u00e9sultats, documentation r\u00e9glement\u00e9e, agenda financier et pr\u00e9sentations : retrouvez toutes les ressources destin\u00e9es aux actionnaires et partenaires.[\/vc_column_text]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-2c7b9910312c8e3f88e42dae2db35a6d.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-2c7b9910312c8e3f88e42dae2db35a6d > i {\n  margin-right: 8px;\n}<\/style><a href=\"#\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off ico-right-side btn-inline-left \" id=\"default-btn-2c7b9910312c8e3f88e42dae2db35a6d\"><span>Espace investisseurs<\/span><i class=\"icomoon-the7-font-the7-link-03\"><\/i><\/a><style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-47a3018bca68bf4ffd8486ec85d92265.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-47a3018bca68bf4ffd8486ec85d92265 > i {\n  margin-right: 8px;\n}<\/style><a href=\"https:\/\/ab-science.excalibra.com\/fr\/pipeline\/\" class=\"default-btn-shortcode dt-btn dt-btn-s link-hover-off revert decalage-gauche btn-inline-left \" id=\"default-btn-47a3018bca68bf4ffd8486ec85d92265\"><span>Contacter l&rsquo;\u00e9quipe<\/span><\/a>[\/vc_column_inner][vc_column_inner css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/3&Prime; css=\u00a0\u00bb.vc_custom_1785953829741{margin-right: 30px !important;border-top-width: 10px !important;padding-right: 0px !important;padding-left: 30px !important;background-color: #FFFFFF !important;border-top-style: solid !important;border-color: #5E87C5 !important;border-radius: 25px !important;}\u00a0\u00bb offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-4 vc_col-sm-inherit\u00a0\u00bb el_class=\u00a0\u00bbcarte-euronext\u00a0\u00bb][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785953636214{padding-right: 20px !important;}\u00a0\u00bb]<\/p>\n<h2><span style=\"color: #eb5b25; font-size: 12px; text-transform: uppercase; letter-spacing: 1.5px;\">EURONEXT PARIS<\/span><\/h2>\n<h3 style=\"margin-top: 40px; margin-bottom: 20px; color: #1d293d; font-size: 100px; font-weight: bold; line-height: 1.2em; letter-spacing: -10px;\">AB<\/h3>\n<p>Soci\u00e9t\u00e9 pharmaceutique fran\u00e7aise \u00e0 stade clinique[\/vc_column_text]<div class=\"ult-spacer spacer-6a749277b626e\" data-id=\"6a749277b626e\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"40\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[vc_raw_html]JTNDaW1nJTBBJTIwJTIwJTIwJTIwY2xhc3MlM0QlMjJkZWNvcmF0aW9uLWV1cm9uZXh0JTIyJTBBJTIwJTIwJTIwJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZhYi1zY2llbmNlLmV4Y2FsaWJyYS5jb20lMkZ3cC1jb250ZW50JTJGdXBsb2FkcyUyRjIwMjYlMkYwOCUyRkxvZ29fRVVST05FWFRfQUJfU0NJRU5DRS0xLnBuZyUyMiUwQSUyMCUyMCUyMCUyMGFsdCUzRCUyMiUyMiUwQSUyMCUyMCUyMCUyMGxvYWRpbmclM0QlMjJsYXp5JTIyJTBBJTIwJTIwJTIwJTIwZGVjb2RpbmclM0QlMjJhc3luYyUyMiUwQSUyRiUzRQ==[\/vc_raw_html][\/vc_column_inner][\/vc_row_inner]<div class=\"ult-spacer spacer-6a749277b62a0\" data-id=\"6a749277b62a0\" data-height=\"20\" data-height-mobile=\"10\" data-height-tab=\"20\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"10\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a749277b62db\" data-id=\"6a749277b62db\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row gap=\u00a0\u00bb0px\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/2&Prime;][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb] La discipline scientifique au service des patients. [\/vc_column_text][vc_column_text css_animation=\u00a0\u00bbnone\u00a0\u00bb]AB Science con\u00e7oit des traitements innovants pour les maladies \u00e0 fort besoin m\u00e9dical non satisfait, avec une priorit\u00e9 : transformer la recherche de pr\u00e9cision en b\u00e9n\u00e9fice clinique.[\/vc_column_text][\/vc_column][vc_column css_animation=\u00a0\u00bbnone\u00a0\u00bb width=\u00a0\u00bb1\/2&Prime; offset=\u00a0\u00bbvc_col-xl-inherit vc_col-lg-inherit vc_col-md-6 vc_col-sm-inherit\u00a0\u00bb][vc_single_image image=\u00a0\u00bb11156&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb css_animation=\u00a0\u00bbnone\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785945735293{background-color: #EAF1FA !important;}\u00a0\u00bb][vc_row_inner gap=\u00a0\u00bb0px\u00a0\u00bb content_placement=\u00a0\u00bbtop\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1785957111741{border-top-width:&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3983","page","type-page","status-publish","hentry","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939<\/title>\n<meta name=\"description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Accueil\" \/>\n<meta property=\"og:description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ab-science.excalibra.com\/fr\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-05T19:12:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\",\"url\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\",\"name\":\"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-09-15T11:52:33+00:00\",\"dateModified\":\"2026-08-05T19:12:50+00:00\",\"description\":\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Accueil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Accueil","og_description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","og_url":"https:\/\/ab-science.excalibra.com\/fr\/","og_site_name":"AB Science","article_modified_time":"2026-08-05T19:12:50+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ab-science.excalibra.com\/fr\/","url":"https:\/\/ab-science.excalibra.com\/fr\/","name":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","isPartOf":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/#website"},"datePublished":"2020-09-15T11:52:33+00:00","dateModified":"2026-08-05T19:12:50+00:00","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","breadcrumb":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ab-science.excalibra.com\/fr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ab-science.excalibra.com\/fr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ab-science.excalibra.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Accueil"}]},{"@type":"WebSite","@id":"https:\/\/ab-science.excalibra.com\/fr\/#website","url":"https:\/\/ab-science.excalibra.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ab-science.excalibra.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ab-science.excalibra.com\/fr\/#organization","name":"AB Science","url":"https:\/\/ab-science.excalibra.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ab-science.excalibra.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]}]}},"_links":{"self":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages\/3983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/comments?post=3983"}],"version-history":[{"count":169,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages\/3983\/revisions"}],"predecessor-version":[{"id":11261,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages\/3983\/revisions\/11261"}],"wp:attachment":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/media?parent=3983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}